MullerLMGorterKJHakEet al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281-288.
2.
DuffMDemidovaOBlackburnSShubrookJ.Cutaneous manifestations of diabetes mellitus. Clin Diabetes. 2015;33:40-48.
3.
WijesuriyaTMWeerasekeraMMKottahachchiJet al. Proportion of lower limb fungal foot infections in patients with type 2 diabetes at a tertiary care hospital in Sri Lanka. Indian J Endocrinol Metab. 2014;18:63-69.
4.
PafiliKMaltezosEPapanasN.The potential of SGLT2 inhibitors in phase II clinical development for treating type 2 diabetes. Expert Opin Investig Drugs. 2016;25:1133-1152.
5.
PafiliKMaltezosEPapanasN.Dapagliflozin for the treatment of type 1 diabetes mellitus. Expert Opin Investig Drugs. 2017;26:873-881.
6.
ArmstrongDGBoultonAJMBusSA.Diabetic Foot ulcers and their recurrence. N Engl J Med. 2017;376:2367-2375.
7.
NdosiMWright-HughesABrownSet al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018;35:78-88.
8.
EckhardMLenglerALierschJBretzelRGMayserP.Fungal foot infections in patients with diabetes mellitus—results of two independent investigations. Mycoses. 2007;50(suppl 2):14-19.
9.
Mlinariæ-MissoniEKaleniæSVukeliæMDe SyoDBeliczaMVaziæ-BabiæV.Candida infections in diabetic foot ulcers. Diabetol Croat. 2005;34:29-35.
10.
NairSPeterSSasidharanASistlaSUnniAKK. Incidence of mycotic infections in diabetic foot tissue. J Cult Collect. 2006;5:85-89.
11.
HealdAHO’HalloranDJRichardsKet al. Fungal infection of the diabetic foot: two distinct syndromes. Diabet Med. 2001;18:567-572.
12.
KalanLLoescheMHodkinsonBPet al. Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. MBio. 2016;7(5):e01058-16.
13.
TorrenceGMSchmidtBM.Fungal osteomyelitis in diabetic foot infections: A case series and comparative analysisInt J Lower Extrem Wounds. 2018. doi:10.1177/1534734618791607.
14.
SangoiARRogersWMLongacreTAMontoyaJGBaronEJBanaeiN.Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution. Am J Clin Pathol. 2009;131:364-375.
15.
VasPPanagopoulosPPapanasN.Editorial: “Ah, Wherefore with Infection Should He Live?” Microbial virulence factors in diabetic foot ulceration. Curr Vasc Pharmacol. 2016;14:498-501.
16.
PapanasNManiR.Advances in infections and wound healing for the diabetic foot: the die is cast. Int J Low Extrem Wounds. 2013;12:83-86.
17.
VasPRJEdmondsMKavarthapuVet al. The diabetic foot attack: “Tis too late to retreat!”Int J Low Extrem Wounds. 2018;17:7-13.
18.
PapanasNManiR. How to cope with the increasing burden of the diabetic foot: “better three hours too soon than a minute too late.”Int J Low Extrem Wounds. 2014;13:171-172.
